Penumbra, Inc. (NYSE:PEN) EVP Johanna Roberts Sells 600 Shares of Stock

Penumbra, Inc. (NYSE:PEN) EVP Johanna Roberts sold 600 shares of the firm’s stock in a transaction that occurred on Monday, June 2nd. The stock was sold at an average price of $258.17, for a total value of $154,902.00. Following the sale, the executive vice president now directly owns 64,714 shares of the company’s stock, valued at $16,707,213.38. This represents a 0.92% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link.

Johanna Roberts also recently made the following trade(s):

• On Monday, May 12th, Johanna Roberts sold 900 shares of Penumbra stock. The stock was sold at an average price of $298.55, for a total value of $268,695.00.
• On Thursday, April 24th, Johanna Roberts sold 600 shares of Penumbra stock. The stock was sold at an average price of $300.01, for a total value of $180,006.00.
• On Tuesday, April 1st, Johanna Roberts sold 600 shares of Penumbra stock. The stock was sold at an average price of $269.11, for a total value of $161,466.00.

Penumbra Price Performance

PEN stock opened at $255.01 on Thursday. The company has a debt-to-equity ratio of 0.02, a current ratio of 6.01 and a quick ratio of 3.25. The business has a 50 day simple moving average of $277.33 and a 200-day simple moving average of $266.45. The firm has a market capitalization of $9.88 billion, a PE ratio of 750.03, a price-to-earnings-growth ratio of 2.83 and a beta of 0.53. Penumbra, Inc. has a 1 year low of $148.00 and a 1 year high of $310.00.

Penumbra (NYSE:PEN) last issued its quarterly earnings data on Wednesday, April 23rd. The company reported $0.83 earnings per share for the quarter, topping the consensus estimate of $0.66 by $0.17. The company had revenue of $324.14 million during the quarter, compared to analyst estimates of $315.72 million. Penumbra had a return on equity of 9.74% and a net margin of 1.17%. The firm’s revenue for the quarter was up 16.3% compared to the same quarter last year. During the same period in the prior year, the business posted $0.41 earnings per share. Equities research analysts anticipate that Penumbra, Inc. will post 3.67 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research analysts have recently issued reports on the company. Stifel Nicolaus set a $318.00 price target on Penumbra and gave the company a “buy” rating in a report on Thursday, April 24th. UBS Group reaffirmed a “buy” rating and set a $330.00 price target (up previously from $320.00) on shares of Penumbra in a research report on Thursday, April 24th. Piper Sandler reaffirmed an “overweight” rating and set a $330.00 price target (up previously from $250.00) on shares of Penumbra in a research report on Wednesday, February 19th. Wall Street Zen cut Penumbra from a “strong-buy” rating to a “buy” rating in a report on Saturday, May 24th. Finally, Needham & Company LLC reissued a “hold” rating on shares of Penumbra in a report on Wednesday, February 19th. Three research analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, Penumbra presently has an average rating of “Moderate Buy” and an average price target of $302.40.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in PEN. Synergy Investment Management LLC purchased a new position in shares of Penumbra during the first quarter worth $27,000. First Horizon Advisors Inc. raised its stake in Penumbra by 404.8% in the first quarter. First Horizon Advisors Inc. now owns 106 shares of the company’s stock valued at $28,000 after buying an additional 85 shares in the last quarter. Hurley Capital LLC acquired a new stake in Penumbra in the fourth quarter valued at $56,000. Huntington National Bank raised its stake in Penumbra by 138.7% in the fourth quarter. Huntington National Bank now owns 265 shares of the company’s stock valued at $63,000 after buying an additional 154 shares in the last quarter. Finally, AlphaQuest LLC purchased a new position in shares of Penumbra during the first quarter worth about $66,000. 88.88% of the stock is currently owned by hedge funds and other institutional investors.

About Penumbra

Penumbra, Inc, together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX.